It is well established that the reinforcing properties of nicotine (NIC) depend on its action on nicotinic acetylcholine receptors expressed by brain neurons. However, when administered systemically, NIC first phasically activates nicotinic receptors located on the afferents of sensory nerves at the sites of drug administration before reaching the brain and directly interacting with central neurons. While this peripheral action of NIC has been known for years, it is usually neglected in any consideration of the drug's reinforcing properties and experiencedependent changes of its behavioral and physiological effects. The goal of this work was to review our recent behavioral, electrophysiological, and physiological data suggesting the critical importance of peripheral actions of NIC in mediating its neural effects following acute drug exposure and their involvement in alterations of NIC effects consistently occurring following repeated drug exposure. Because NIC, by acting peripherally, produces a rapid sensory signal to the central nervous system that is followed by slower, more prolonged direct drug actions in the brain, these two pharmacological actions interact in the central nervous system during repeated drug use with the development of Pavlovian conditioned association. This within-drug conditioning mechanism could explain the experience-dependent changes in the physiological, behavioral, and human psychoemotional effects of NIC, which, in drug-experienced individuals, always represent a combination of pharmacological and learning variables.
Introduction
It is well established that nicotine's (NIC's) action on centrally located nicotinic acetylcholine receptors is essential in mediating its reinforcing properties (Picciotto and Corrigall, 2002) . However, before reaching the brain and interacting with these receptors, NIC transiently activates nicotinic receptors on the afferents of sensory nerves at the sites of its entry (i.e., lung alveoli and nasal and oral cavities) and within the circulatory system (Ginzel, 1975; Steen and Reeh, 1993; Anand, 1996; Liu and Simon, 1996; Walker et al., 1996; Jonsson et al., 2002) . Although it is known that this peripheral action of NIC is essential in mediating its primary sensory and cardiovascular effects (Comroe, 1960; Ginzel, 1975; Anand, 1996) , it is usually neglected in considerations of the drug's reinforcing properties and experience-dependent changes in its behavioral and physiological effects (see, however, Engberg and Hajos, 1994; Bevins et al., 2012) . The goal of this work was to review our recent behavioral, electrophysiological, and physiological findings (Tang and Kiyatkin, 2010; Lenoir and Kiyatkin, 2011; Lenoir et al., 2013) suggesting the critical importance of the peripheral actions of NIC in mediating its neural effects following acute and chronic exposure. On the basis of these data, we substantiate the hypothesis that the peripheral actions of NIC, by creating a rapid neural signal and interacting with subsequent direct drug actions in the brain, play an important role in the development of NIC-selective neural sensitization -a basic phenomenon underlying experience-dependent changes in the behavioral, physiological, and psychoemotional effects of this drug occurring during its repeated exposure.
Techniques used for evaluating the neural effects of NIC following acute and repeated exposure
For direct evaluation of NIC-induced changes in neural activity and their underlying mechanisms, we used electroencephalography (EEG) with subsequent high-speed analysis of its power and frequency characteristics. To assess the structural specificity of the neural response, electrical activity was simultaneously recorded from the cortex and the ventral tegmental area (VTA), a critical structure of the motivational-reinforcement circuit (Wise, 2004) . The great advantage of EEG is its dynamic nature, allowing a high-speed (second scale) analysis resolution that is critical for evaluating the latency and time course of rapid neural responses. In addition to EEG, we also recorded neck electromyographic (EMG) activity, a centrally mediated physiological parameter that reflects tonic and phasic changes in motor output. In contrast to locomotion that is insensitive or of little value during certain behavioral responses (i.e., fear-related freezing, intense stereotypy), EMG activity is highly sensitive to even very weak sensory stimuli such as an audio signal or intravenous (iv) saline injection (Kiyatkin and Smirnov, 2010) . In contrast to single-unit recording, which has a number of significant limitations when used in freely moving rats (i.e., cell heterogeneity, silent/active cells, limited recording time, necessity of large data samples), EEG and EMG signals may be recorded with high temporal resolution for extended periods following repeated daily sessions in the same animals, providing an integral measure of basal activity state and event-related neural and motor responses. While the total power of the EEG signal, a universal measure of electrical synchronization/desynchronization (Steriage and McCarley, 2005; Buzsaki, 2006) , was the primary parameter for evaluating the dynamics of neural response, additional information on alterations in neural activity was obtained by EEG spectral analysis, which can reveal dynamic, time-dependent alterations in specific activity bands. While nonspecific with respect to individual neurons, frequency analysis of the EEG signal provides valuable information on activity changes of large neuronal populations.
For assessing the physiological effects of NIC and their changes following repeated drug exposure, we used thermorecordings in freely moving rats. Similar to the electrophysiological studies, these recordings were conducted in chronic experiment, thus allowing an examination of the temperature effects of NIC and related drugs during multiple sessions. In these studies, temperatures were monitored from three locations: the brain (nucleus accumbens or NAcc), temporal muscle, and facial skin. While brain temperature is an important homeostatic parameter, it fluctuates in rats within a relatively large range (3°C-4°C), normally at low levels during slow-wave sleep and increasing in response to various arousing stimuli, during various behaviors, and after exposure to different drugs (see for review, Kiyatkin, 2010 Kiyatkin, , 2013 . Since brain temperature depends upon metabolism-related intrabrain heat production and heat dissipation by cerebral blood flow, simultaneous temperature recording from the temporal muscle makes it possible to reveal a component of brain temperature response related to metabolic neural activity. While drug-induced changes in metabolic neural activity could be also evaluated by using positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) and these approaches were used to study NIC in humans (Garavan et al., 2000; Stapleton et al., 2003; Zuo et al., 2011) , these techniques are based on indirect measures (glucose metabolism or fluctuations in local cerebral blood flow) and are not applicable in behaving animals. In contrast, brain temperature could be recorded in freely moving rats with high temporal resolution during multiple sessions, thus making possible to examine experiencedependent changes in drug responses. Skin temperature provides a sensitive index of peripheral vasoconstriction, the known effect of any arousing stimuli and NIC (Altschule, 1951; Comroe, 1960; Ginzel, 1975; Baker et al., 1976) .
Our electrophysiological and temperature recordings were combined with the monitoring of locomotion as an index of behavioral activation. It is well known that NIC affects locomotion and its repeated intermittent administration results in progressive enhancement or sensitization of drug-induced locomotor responses (Clark and Kumar, 1983; Benwell and Balfour, 1992; Domino, 2001; Vezina et al., 2007; Mao and McGehee, 2010) . Thus, this simple measure allowed us to correlate changes in physiological parameters with animal behavior elicited by acute and repeated NIC exposure. Moreover, this parameter was important to clarify the role of peripheral drug actions by using peripherally acting nicotinic agonists and antagonists (see below).
Pharmacological tools for evaluating the contribution of peripheral vs. central actions of NIC
In our studies, we employ iv NIC ([-] nicotine hydrogen tartrate) injections at a low, behaviorally relevant dose (10-30 μg/kg) that is optimal for the development and maintenance of operant self-administration behavior in rats (Cox et al., 1984; Donny et al., 1995) . This NIC formulation easily crosses the blood-brain barrier (BBB), thus acting on both peripherally and centrally located nicotinic receptors. Although humans use NIC preferentially by smoking, providing rapid drug entry to the brain (Berridge et al., 2010; Rose et al., 2010) , iv injection, compared with other means of drug delivery, is a valid route of drug administration in rats to study the basic mechanisms underlying its neural and physiological effects.
To examine the contribution of peripheral actions of NIC to its neural effects, we used two pharmacological tools, hexamethonium bromide (HEXA) and NIC pyrrolidine methiodide (NIC PM ), highly charged molecules that are unable to cross the BBB (Barlow and Dobson, 1955; Wassermann, 1972; Ginzel, 1973 Ginzel, , 1975 Aceto et al., 1983; Oldendorf et al., 1993; Woods et al., 2008) . By using HEXA pretreatment, we were able to examine how the blockade of peripheral actions of NIC affects its acute neural and behavioral effects and their changes following repeated NIC administration. In contrast, NIC PM activates only the peripheral pool of nicotinic receptors, thus allowing the examination of their impact in mediating the neural and behavioral effects of NIC. Although we recently confirmed, by using ultrasensitive mass spectrometry, that NIC PM cannot be detected in brain tissue after iv administration at a dose of 0.1 mg/kg (Lenoir et al., 2013) , direct data on its affinity with respect to different subtypes of nicotinic and other receptors remain unknown. However, a basic similarity in receptor affinity of both molecules could be suggested because intraventricular administration of both drugs induces similar antinociceptive effects, and these effects are attenuated by mecamylamine, a nonselective antagonist of nicotinic acetylcholine receptors (Aceto et al., 1983) . Finally, NIC PM could serve another important purpose when used in NIC-experienced individuals. If the peripheral actions of NIC are critical for the development of neural sensitization, activation of peripheral nicotinic receptors in these NIC-experienced individuals should induce a conditioned neural or physiological response, which is different from the initial effect of this drug before NIC treatment.
Acute effects of NIC
When recorded in freely moving rats extensively habituated to the recording environment, the electrical activity in both the cortex and VTA typically shows high-magnitude, low-frequency fluctuations (synchronized activity), which are transiently interrupted by episodes of low-magnitude, high-frequency activity that occur either spontaneously or in response to sensory stimuli. While the synchronized activity is a typical electrophysiological feature of slowwave sleep, the so-called desynchronized activity is an index of neural activation. As shown in Figure 1 , iv NIC injection at a low self-administering dose results in very rapid and almost synchronous change in cortical and VTA EEG signals and, a little later, the appearance of strong EMG activation. Importantly, the NIC-induced EEG desynchronization does not differ qualitatively from a transient activation response that occurs after iv saline injection, a weak visceral sensory stimulus, but it is much stronger and longer quantitatively. NIC-induced EEG desynchronization was drastically delayed during urethane-induced anesthesia, suggesting the importance of natural physiological conditions (freely moving animal) to observe undisturbed drug-induced neural effects.
During quantitative analyses of EEG activities ( Figure 2 , left panel), we found that EEG total power was rapidly decreased by NIC, reaching significance in the middle of a 15-s injection. Importantly, this rapid effect The left panel shows mean ± SEM changes in cortical (A) and VTA EEG (B) and EMG total powers (C) and the two right panels (D-H) show mean ± SEM changes in individual EEG frequency bands (δ, θ, α, β, γ) separately for the cortex and VTA. Filled symbols show values significantly different from those at baseline. Original data were presented in Lenoir and Kiyatkin (2011) , where all details of the protocol and statistical analyses could be found.
was very similar in both the cortex and VTA and for two low doses (10 and 30 μg/kg), while its duration was clearly shorter for a smaller dose (Figure 2A ,B). The EMG signal showed similar dynamics, but the changes were quantitatively larger ( Figure 2C ). The total power of this signal began to increase during the NIC injection, peaked immediately after its end, and slowly decreased thereafter. The electrophysiological effects of NIC clearly differed in its magnitude and duration from the effects of saline, which also induced a rapid decrease in EEG total power and a small EMG response.
Rapid, powerful effects were found when the EEG signal was divided into individual frequency bands ( Figure 2 , right panel). In this case, α activity decreased ( Figure 2F ) and high-frequency β and γ activities increased ( Figure 2G ,H), representing the classic EEG activation triad typical of any arousing stimuli. These changes were equally rapid for both low NIC doses and were similar in both structures, with slightly stronger effects for 30 μg/kg. NIC administration also decreased low-frequency δ activity; these effects were identical in both structures and for both drug doses. In contrast, cortical θ activity rapidly and transiently increased only after NIC at 30 μg/kg, but this type of activity decreased in the VTA for 4-6 min after injection. Although saline injection also induced similar effects and while they were equally rapid, they were much weaker and more transient ( < 1 min).
NIC injected at a low dose (30 μg/kg) also induced relatively weak locomotor activation and small downup-down changes in NAcc and muscle temperatures but strongly decreased skin temperature, suggesting peripheral vasoconstriction ( Figure 3A-C) . These effects continued for about 20 min after injection. Skin temperature decrease occurred with the shortest latency, within or immediately after the injection. After the NIC injection, temperature in the NAcc increased more rapidly than in the muscle, suggesting a transient metabolic neural activation, evident within 8-10 min after injection ( Figure 3B ). In contrast, a decrease in skin-muscle differential, the most accurate measure of peripheral vasoconstriction, was stronger and much more prolonged, being evident within 20-30 min after injection.
Time (min)
Time ( 
The role of peripheral actions of NIC in mediating its acute neural effects
To evaluate the role of peripheral actions of NIC in mediating its central effects, two pharmacological strategies were used. First, we used an antagonist strategy and examined how the electrophysiological and behavioral effects of NIC are affected by HEXA pretreatment. Second, we used an agonist strategy to examine to what extent NIC PM , a peripherally acting NIC analog, mimics the effects of NIC. As shown in Figure 4 , HEXA pretreatment (5 mg/kg, iv, 8 min preceding NIC injection) significantly attenuated NIC-induced EEG desynchronization in both the cortex and VTA (panels A and B). While NIC after HEXA pretreatment continued to rapidly decrease EEG total powers in both brain structures, all effects were significantly weaker than those before drug pretreatment and close to those Original data were presented in Lenoir and Kiyatkin (2011) .
induced by saline injections. HEXA pretreatment also drastically attenuated NIC-induced EMG activation, but this effect was clearly larger than that induced by saline ( Figure 4C ). Similar to NIC, NIC PM induced rapid EEG desynchronization and EMG activation, but its effects were drastically shorter than those of NIC ( Figure 4D ,E). The effects of NIC PM in drug-naive rats resembled those of saline, but they were significantly stronger and more prolonged for each parameter. NIC PM also resembled NIC in its effects on NAcc, muscle, and skin temperatures ( Figure 3D-F) . In both cases, locomotor activity as well as NAcc and muscle temperatures slightly increased after iv administration of both drugs in equal doses (30 μg/kg). Although NIC PM also decreased skin temperature, this effect was clearly weaker than that of NIC.
To directly test how blockade of peripheral nicotinic receptors affects the locomotor effects of NIC, locomotor activity was monitored in four groups of rats that received different treatments (saline-saline, HEXA-saline, saline-NIC, HEXA-NIC). In contrast to all our studies in which drugs were delivered under stress-and cue-free conditions, in this experiment, drugs were injected iv but manually via an injection port on the animal's head. With this type of administration, both saline control and NIC injections resulted in similar levels of locomotor activation ( Figure 5 ). In contrast, iv injection of HEXA (5 mg/kg) induced much weaker locomotor activation than saline did, suggesting its attenuating effect on the saline-induced motor response. This SAL-HEXA difference was evident for ~10 min after injection, corresponding to the duration of HEXA effect with iv administration. The same inhibiting effect was seen in another HEXA group that received NIC injection, and the locomotor effects of NIC were strongly attenuated by HEXA pretreatment. This effect was evident for both the immediate and long-term effects of NIC. A total locomotor response in this group was significantly weaker than in the saline-saline and HEXA-saline groups ( Figure 5B) . Hence, NIC's action on peripherally located nicotinic receptors is a significant factor in drug-induced locomotor activation.
Experience-dependent changes in neural, physiological, and behavioral effects of NIC Similar to other drugs of abuse, the locomotor effects of NIC are enhanced or sensitized following repeated intermittent drug injections (Clark and Kumar, 1983; Benwell and Balfour, 1992; Domino, 2001; Vezina et al., 2007; Mao and McGehee, 2010) . Consistent with these data, we found that rats that received 6 iv NIC injections during two treatment days and tested after one drug-free day showed a significantly larger locomotor response to NIC ( Figure 6A ). While the overall magnitude of the sensitized response increased two-fold, locomotion occurred with shorter latencies and peaked at earlier times after drug administration. We also found that repeated NIC experience dramatically affects the temperature effects of NIC, with a significant, robust enhancement of brain and muscle temperature elevations and a stronger decrease in skin temperatures ( Figure 6A,B) . In addition, an increase in the NAcc-muscle differential, an index reflecting metabolic brain activation (Kiyatkin, 2010) becomes larger and a decrease in skin-muscle differential becomes more pronounced, reflecting a stronger vasoconstrictive effect of NIC. Therefore, not only the locomotor but also the physiological effects of NIC are enhanced or sensitized after previous drug experience.
In contrast to the physiological effects, EEG desynchronization and EMG activation remained equally strong in NIC-experienced animals but became more prolonged ( Figure 7A-C) . A weak enhancement was found only for the immediate effects of NIC in the cortex ( Figure 7G,H) . In contrast to the stability of the electrophysiological effects of NIC, both the EEG and EMG effects induced by NIC PM became weaker or habituated after previous experience with this drug (Figure 7D-F) . This effect was evident in each structure for both the immediate and long-term effects of the drug ( Figure 7G,H) . Therefore, the acute neural effects of NIC remain relatively stable following repeated experience, but the effects of selective activation of peripheral nicotinic receptors rapidly habituate following repeated use of NIC PM . Asterisks in panel B denote statistical difference vs. saline and the small circle denotes difference between two NIC groups (at least p < 0.05). Original data were presented in Lenoir et al. (2013) .
The role of peripheral actions of NIC in the development of NIC-induced neural sensitization
If the peripheral actions of NIC are important for the development of NIC-induced neural sensitization, the effects of selective activation of peripheral nicotinic receptors by NIC PM should be changed in animals after NIC experience. Similar to the appearance of a conditioned response to sensory stimulus repeatedly paired with natural reinforcers such as food, NIC PM used in NIC-experienced subjects could induce a conditioned response. As shown in Figure 8A , NIC PM used in NIC-experienced rats induced much stronger physiological effects than those seen with this substance in drug-naive rats. In this case, it induced strong increases in NAcc and muscle temperatures and strong decreases in skin temperatures, which were significantly larger than those induced by this drug in drug-naive conditions. Because the effects of NIC PM underwent habituation following its repeated exposure, even larger differences were found between the effects of NIC PM in rats repeatedly exposed to either NIC or NIC PM . This strong change in physiological effects contrasted to NIC PM -induced locomotion, which did not change significantly after NIC experience ( Figure 8B ). Dramatic changes in temperature effects of this drug are especially evident with rapid time-course resolution analysis ( Figure 8C ). In this case, both the increases in NAcc temperature and decreases in skin temperature induced by NIC PM in NICexperienced rats were similar to those induced by NIC itself. They also were quite different from the initial effects of this drug. Therefore, a clear conditioned activation was Figure 7 Electrophysiological effects of iv NIC (30 μg/kg) remain highly stable after drug experience, with a tendency to prolongation, but the same effects of NIC PM (30 μg/kg) habituate following repeated drug exposure. The two left columns show changes in total power of cortical EEG (A and D), VTA EEG (B and E), and neck EMG (C and F) induced by NIC (30 μg/kg) in drug-naive and experienced rats. The right column shows between-group differences, shown separately for rapid (5-60 s) and slow (60-600 s) components of electrophysiological responses. Asterisks indicate statistical significance between groups: *p < 0.05, ***p < 0.001. Original data were presented in Lenoir et al. (2013) .
evident in this case at the physiological level, but it was absent at the level of locomotion. Rapid development of conditioned neural activation was also evident in our electrophysiological data. After a relatively short NIC experience (2 days, 6 injections), NIC PM induced a strong and prolonged EEG desynchronization and powerfully increased EMG activity ( Figure 9A ), greatly exceeding the effects of this drug in both drug-naive and experienced (with repeated NIC PM injections) conditions ( Figure 9B) .
To examine the role of peripheral actions of NIC in the development of drug-induced locomotor sensitization, we also used a pharmacological strategy. In this case, we compared the NIC-induced locomotor activation (30 μg/kg) in two groups of rats that received identical NIC pretreatment (6 iv injections at a dose of 30 μg/kg during 2 days), with each NIC injection preceded (-5 min) by the injection of either saline or HEXA (5 mg/kg). In addition to these two active drug treatment groups, NIC-induced locomotion was assessed in rats of two control groups that received saline-saline and HEXA-saline pretreatment. Figure 10 shows the final result of this experiment, namely, the mean locomotor response induced by NIC in rats with different pretreatment histories (saline-saline, HEXA-saline, saline-NIC, HEXA-NIC).
This experiment produced two primary findings. First, it confirmed that repeated NIC exposure enhances the acute locomotor effects of NIC. Second, in rats that received NIC after HEXA pretreatment, the locomotor effects of NIC were drastically reduced, suggesting a full blockade of the development of locomotor sensitization. Unexpectedly, NIC-induced locomotion in rats after HEXA-NIC pretreatment (blue) was (A-C) Changes in NAcc, muscle, and skin temperature (top) and NAcc-muscle and skin-muscle temperature differentials (middle) and locomotion induced by NIC PM (30 μg/kg) in rats after NIC experience (six injections during 2 days). (B) Between-group differences [circles show differences vs. the NIC PM (naive) group; asterisks show differences between the NIC PM (NIC PM ) and NIC PM (NIC) groups; and hash symbol shows differences between the NIC PM (NIC) and NIC (NIC) groups; all p < 0.05). (C) Initial temperature effects analyzed at high temporal resolution. Original data were presented in Lenoir et al. (2013) .
significantly weaker than that found in rats that had never received NIC (black). While this finding was unexpected, it could be related to procedural differences in this experiment. In contrast to our electrophysiological and thermorecording studies, in which drugs and saline were delivered via catheter extensions, thus excluding any stressful influences associated with iv injections, all injections in our behavioral experiment were performed manually into the injection ports on the rat's head. Under these conditions, saline induced locomotor activation (see Figure 5) , which became weaker with repeated injections. Therefore, the locomotor response to the first NIC injection (but after six previous saline injections) in the control saline-saline group could have been enhanced due to a habituation of the motor effects induced by the procedure of drug administration. While this explanation seems valid, the definite reasons for this difference remain unclear and are under investigation now.
General discussion
NIC after iv injection is rapidly distributed by the circulating blood within the body, affecting multiple nicotinic acetylcholine receptors widely expressed in the peripheral The left column shows changes in total power of cortical EEG (A), VTA EEG (B), and neck EMG (C) induced by NIC PM (30 μg/kg) in rats that received previous treatment with either NIC or NIC PM . The right panel shows between-group differences in these parameters separately for rapid (5-60 s) and slow (60-600 s) components of electrophysiological responses. Green lines in panels A-C show time intervals with significant between-group differences. Asterisks in panels D-F show statistical significance between groups: ***p < 0.001. Original data were presented in Lenoir et al. (2013) .
and central nervous system. In this case, NIC local concentrations fall rapidly from very large values at the site of administration to much lower levels in distant body locations, including the brain (Berridge et al., 2010; Rose et al., 2010) . Although NIC's action on centrally located nicotinic receptors is essential in mediating its reinforcing properties and its ability to induce NIC dependence (Picciotto and Corrigall, 2002) , the studies reviewed here suggest that the rapid, transient action of NIC on the afferents of sensory nerves at the administration sites plays an important role in mediating the acute neural effects of this drug and their consistent changes following drug experience.
Peripheral and central contributions to NIC's neural effects
NIC PM , a highly charged NIC analog, which does not enter the brain after systemic administration, is an important tool to dissociate the peripheral actions of NIC from its central ones. When used in drug-naive conditions, NIC PM mimicked the electrophysiological effects of weak natural somatosensory stimuli, inducing transient EEG desynchronization and brief EMG activation. Consistent with the known habituation of neural effects induced by simple somatosensory stimuli (Hendry et al., 1999; Stancak, 2006; Sandler and Tsitolovsky, 2008) , the electrophysiological effects of NIC PM significantly weakened (i.e., habituated) following repeated drug exposure. Decreases in neural activation induced by NIC PM paralleled EMG changes, suggesting that habituation also extends to peripheral motor output. The arousing effects of NIC PM virtually fully disappeared so they became similar to those of iv saline after minimal experience. The electrophysiological effects of regular NIC, which acts both in the brain and periphery, were much stronger than those of NIC PM , suggesting central drug actions as a major contributor. Moreover, the effects of NIC did not habituate following repeated drug use. In both drug-naive and drug-experienced conditions, NIC induced equally strong EEG desynchronization and EMG activation, which became more prolonged in rats previously exposed to NIC. The NICinduced EMG activation also remained equally strong in both groups, suggesting the lack of experience-dependent habituation in drug-induced motor output. This finding suggests the differences between EMG, which reflects tonic and phasic changes in muscular activity, and locomotion, which clearly increases following repeated NIC exposure.
Conditioned neural activation induced by NIC PM after NIC experience
While the neural and motor effects of NIC PM rapidly habituated to the levels produced by saline, this drug induced powerful EEG desynchronization after NIC experience. This effect could be viewed as a manifestation of conditioned neural activation triggered by a selective activation of the peripheral pool of nicotinic receptors. This effect was equally strong in the cortex and VTA, which both shows mean values of locomotion (for 20 min after injection) induced by NIC (30 μg/kg) in rats exposed to different pretreatments (saline-saline, HEXA-saline, saline-NIC, HEXA-NIC). Rats that were previously exposed to NIC showed significantly larger or sensitized locomotor responses to this drug, but when NIC injections were conducted after HEXA pretreatment, locomotor response to NIC was significantly smaller. Asterisk in panel A shows time interval, where differences between HEXA-NIC and saline-NIC were significant ( p < 0.05). Asterisks in panel B show significance of between-group differences: *p < 0.05, ***p < 0.001.
showed robust increases in high-frequency β and γ, which greatly exceeded those induced by this drug in both drugnaive and experienced conditions and were quite similar to those induced by NIC itself. This change was coupled with strong EMG activation, suggesting that conditioning also occurs at the level of centrally regulated motor output. Robust conditioned activation was also found at the levels of physiological parameters. In contrast to the very weak activating effects of NIC PM in drug-naive conditions, the same drug in the same dose induced strong increases in brain and muscle temperatures and powerful and prolonged peripheral vasoconstriction -the novel effects not seen both before NIC pretreatment and after repeated pretreatment with NIC PM . By these parameters, the effects of NIC PM after previous NIC exposure were stronger than the initial effects of NIC itself and similar to the effects induced by NIC after previous exposure. However, powerful potentiation of the electrophysiological and physiological effects of NIC PM was not accompanied by changes in locomotion, which remained the same regardless of pretreatment.
Conclusions and functional implications
Although associative learning is viewed as an important contributor to drug-induced behavioral sensitization (Kalivas and Stewart, 1991; Robinson and Berridge, 1993; Di Chiara, 2000) , it is usually considered as the result of interaction between environmental stimuli that precede drug intake and the drug per se. However, this stimulus-drug interaction could be more complex in the case of NIC, which, by itself, has two different, timeshifted actions that are mediated via the drug's interaction with peripherally and centrally located nicotinic receptors. The data presented in this review suggest the critical role of peripheral actions of NIC in mediating its rapid neural and physiological effects. In addition to the pharmacological evidence provided by using peripherally acting nicotinic agonists and antagonists, very short, second-scale latencies of NIC-induced neural activation are inconsistent with possible direct actions of NIC in the brain. A certain time is always necessary for the drug to reach brain vessels from the site of administration, cross the BBB, and diffuse passively to the appropriate receptor sites. In contrast, NIC rapidly but transiently activates nicotinic receptors abundantly expressed on afferents of sensory nerves at the sites of its entry (e.g., lung alveoli, nasal and oral cavities) and within the circulatory system (Ginzel, 1975; Steen and Reeh, 1993; Anand, 1996; Liu and Simon, 1996; Walker et al., 1996; Jonsson et al., 2002) and induces an excitatory neural signal that rapidly reaches the brain via visceral somatosensory pathways. While this study clarifies the nature of this first, rapid, and transient action of NIC, it is still unclear at the mechanistic level how the neural effects triggered by this peripheral action are affected by the direct actions of NIC on brain neurons. This direct central action appears with much longer latencies and is maintained for a longer time after systemic drug administration at human-relevant doses, and this action is critical for fixation in memory of traces associated with the initial, sensory effects of NIC, possibly playing a key role in NIC reinforcement (Huston and Mondadory, 1977; Huston and Oitzl, 1989) . While it is well established that this direct action of NIC on brain neurons is essential for the development of NICinduced neural sensitization, the present studies provide clear evidence that the peripheral actions of NIC are also critically involved in this process. The coexistence in NIC of two initially independent pharmacological actions that are mediated via peripheral and central nicotinic acetylcholine receptor allows their interaction within the same neural substrates based on principles of Pavlovian conditioning. Due to this interaction, the initial sensory effects of NIC acquire new properties of interoceptive cues, thus affecting the changes in the behavioral and physiological effects of this drug after repeated exposure. Therefore, the development of conditioned association could occur not only for external (exteroceptive) stimulus and the reinforcer (drug) but also to the drug itself (pharmacological or within-drug conditioning), which shares the dual properties of a sensory stimulus and reinforcer. Therefore, the effects of the drug in experienced individuals are always different from those seen in drug-naive individuals, and they always represent 'conditioned drug effects', reflecting a joint contribution of pharmacological and learning variables (Stewart, 1992) .
The ability of NIC to serve as its own sensory signal could explain its high addictive potential in humans and the rapid transformation of experimental smoking into a highly compulsive habit. Similar to the known shift of neural activation from a primary reinforcer to its sensory predictors (Schultz, 1998) , the initially unpleasant or aversive sensory stimulation associated with NIC consumption (smoking per se) becomes, in drug-experienced individuals, the source of powerful neural activation and the most desired aspect of smoking. Consistent with this idea, smoking becomes much less rewarding and satisfying when the peripheral actions of NIC on the sensory afferents of the upper respiratory tract are blocked by local anesthetics (Rose et al., 1985) . On the other hand, the interoceptive actions of NIC provide only a part of sensory experience of smoking, explaining why habitual smokers often perceive similar immediate subjective and autonomic responses during smoking of NIC-free cigarettes (Butschky et al., 1995; Westman et al., 1996) . Obviously, these responses are triggered by multiple non-NIC sensory stimuli associated with smoking, which, in smokers, become powerful conditioned stimuli. This basic mechanism of pharmacological conditioning could explain the persistent nature of NIC addiction in humans and limited success in its pharmacological correction. On the other hand, it suggests that attempts to reduce NIC addiction could be more effective if they also target the immediate conditioned effects of the drug rather than focusing exclusively on decreasing its unconditioned rewarding effects in the brain.
